1. Stocks
  2. Orchid Pharma Ltd.
  3. Swot
swot-logo

Orchid Pharma Ltd. SWOT Analysis: Strengths, Weakness, Opportunity, and Threats

Orchid Pharma Ltd. has 6 Strengths, 18 Weaknesses, 2 Opportunities and 2 Threats. The SWOT product gives you a quick x-ray of a stock's outlook and potential

Add SWOT widget to your site/app

Consistent Highest Return Stocks over Five Years

Companies with Low Debt

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Volume Shockers

Companies with growing costs YoY for long term projects

Companies that Declared Results in Past One Week, Showing Declining Net Profit YoY OR QoQ (subscription)

PEG greater than Industry PEG

New 52 week low today

Bearish Stocks - Stocks with Medium to Low Trendlyne Momentum Score

Lowest Momentum Scores (Technical Scores)

Oversold by Money Flow Index (MFI)

Stocks with Expensive Valuations according to the Trendlyne Valuation Score

Slowing Down Stocks (DVM)

Low Piotroski Score : Companies with weak financials

Weak performer : Stock lost more than 20% in 1 month

Weak Momentum: Price below Short, Medium and Long Term Averages

High volume, top losers

RSI indicating price weakness

Highest fall from 52 Week High

Top Losers

Near 52 Week Low

Stocks Underperforming their Industry Price Change in the Quarter

FII / FPI or Institutions increasing their shareholding

MFs increased their shareholding last quarter

Red Flags: Firms linked to ongoing regulatory investigations/legal cases

Red Flags: Weakening Technicals and Share Price Decline

Average Financial Performers - Stocks with Medium Trendlyne Durability Score versus Benchmarks

New 52 Week Low